PHARMA TECH

Denver's SmartTab combines modern technology with everyday drug capsule

August 11, 2022

A startup pharmaceutical company in Denver is working on a way to deliver much-needed medication through a high-tech capsule. You're In Good Company with SmartTab.

Spotlight

Vertex Pharmaceuticals

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

OTHER VIDEOS

Computational Drug Discovery and Design

video | October 2, 2022

Computational Drug Designing has become the go-to requirement for the researchers, scientists and the pharmaceuticals who fight against the fatal disease....

Watch Now

How Important is Data Integrity to Your Lab Work?

video | September 28, 2022

As a compliance leader performing over 30,000 Operational Qualifications every year, Agilent continues to invest in solutions that address the needs of the market....

Watch Now

Pharmacy Management Software

video | October 1, 2022

Unipro Software Pte Ltd is a home grown software company which provides software services and system integration services to many organisations....

Watch Now

Huawei Cloud AI Model Accelerates New Drug Discovery

video | September 22, 2022

pre-trained AI models have greatly sped up pharma R&D, with multi-year tasks, such as identify lead compounds,...

Watch Now

Spotlight

Vertex Pharmaceuticals

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Events